Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3428]
News [7862]
Articles [63]
Editorials [9]
Conferences [212]
elearning [49]
Improving outcomes of childhood neuroblastoma
Dr Garrett Brodeur - Cancer Center at The Children’s Hospital of Philadelphia...
Improving outcomes of childhood neuroblastoma ( Dr Garrett Brodeur - Cancer Center at The Children’s Hospital of Philadelphia, USA )
1 Jun 2013
Nivolumab produces long-lasting responses in patients with stage IV melanoma
Dr Mario Sznol - Yale Cancer Center, New Haven, USA
Nivolumab produces long-lasting responses in patients with stage IV melanoma ( Dr Mario Sznol - Yale Cancer Center, New Haven, USA )
1 Jun 2013
Delayed relapse of advanced ovarian cancer when treating with pazopanib
Dr Andreas du Bois - Kliniken Essen Mitte, Essen, Germany
Delayed relapse of advanced ovarian cancer when treating with pazopanib ( Dr Andreas du Bois - Kliniken Essen Mitte, Essen, Germany )
1 Jun 2013
Cetuximab superior to bevacizumab for advanced colorectal cancer
Dr Volker Heinemann - University of Munich, Germany
Cetuximab superior to bevacizumab for advanced colorectal cancer ( Dr Volker Heinemann - University of Munich, Germany )
1 Jun 2013
New MEK inhibitor selumetinib is the first effective drug for advanced melanoma...
Dr Richard D. Carvajal - Memorial Sloan-Kettering Cancer Center, New York, USA
New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye ( Dr Richard D. Carvajal - Memorial Sloan-Kettering Cancer Center, New York, USA )
1 Jun 2013
Anti-PD-1 drug nivolumab shows high and durable clinical activity in patients...
Dr Mario Sznol - Yale Cancer Center New Haven, USA
Anti-PD-1 drug nivolumab shows high and durable clinical activity in patients with advanced melanoma ( Dr Mario Sznol - Yale Cancer Center New Haven, USA )
1 Jun 2013
Maintenance therapy with multi-targeted drug pazopanib delays relapse of...
Dr Andreas du Bois - Kliniken Essen Mitte, Germany
Maintenance therapy with multi-targeted drug pazopanib delays relapse of advanced ovarian cancer ( Dr Andreas du Bois - Kliniken Essen Mitte, Germany )
1 Jun 2013
Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone
Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
1 Jun 2013
State of CNS germ cell tumour research in North America
Dr Stewart Goldman - Children's Memorial Hospital, Chicago, Illinois, USA
State of CNS germ cell tumour research in North America ( Dr Stewart Goldman - Children's Memorial Hospital, Chicago, Illinois, USA )
29 May 2013
Overview of germ cell tumour research in North America
Dr Stewart Goldman - Children's Memorial Hospital, Chicago, Illinois, USA
Overview of germ cell tumour research in North America ( Dr Stewart Goldman - Children's Memorial Hospital, Chicago, Illinois, USA )
29 May 2013
New targets for squamos cell carcinoma
Dr Martin Reck – Hospital Grosshansdorf, Wohrendamm, Germany
New targets for squamos cell carcinoma ( Dr Martin Reck – Hospital Grosshansdorf, Wohrendamm, Germany )
16 May 2013
European Thoracic Oncology Platform
Dr Solange Peters - Lausanne University, Switzerland
European Thoracic Oncology Platform ( Dr Solange Peters - Lausanne University, Switzerland )
16 May 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation